In a recent announcement, Concord, a well-known music rights investor, has confirmed its agreement to purchase Hipgnosis Songs Fund Ltd. The acquisition of the song cataloging company has a projected value of approximately $1.4 billion. Full report by Bloomberg Law.
The bidders proposed a cash per share price of $1.16 to Hipgnosis investors, marking a substantial 32% premium from the preceding closing price. Both parties shared the details of this proposal in a joint statement released last Thursday.
The decision to accept this proposed deal received unanimous support from the board of directors at Hipgnosis. Despite the company’s performance, they noted that a rise in share price might not occur due to a combination of “numerous company-specific and certain market issues”.
Upon release of the news, at 8.06 a.m. London time, Hipgnosis’ shares experienced a significant surge, rising by 31%.